D-19 pandemic Novo Nordisk® US GLP-1 prescription development during COVID-19 pandemic TRx count (thousands) 2,000 TRx NBRx (RHS) 1,600 1,200 800 400 0 Nov 2018 NBRx count (thousands) 13 March, lockdown implemented in most states 140 120 100 80 60 40 20 0 Oct 2020
Download PDF file